Quarterly report · Q1
2370.TEDINET S100SUKD
Period2023-10-01 → 2023-12-31
Filed2024-02-13
StandardJapan GAAP
ConsolidatedNo
Data checks10 of 10 passed
Key figures · 32
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥248m | 2023-10-01 → 2023-12-31 | Standalone | Net sales |
| Revenue | ¥662m | 2022-10-01 → 2023-09-30 | Standalone | Net sales (5-year summary) |
| Revenue | ¥185m | 2022-10-01 → 2022-12-31 | Standalone | Net sales |
| Operating income | −¥294m | 2023-10-01 → 2023-12-31 | Standalone | Operating income |
| Operating income | −¥325m | 2022-10-01 → 2022-12-31 | Standalone | Operating income |
| Ordinary income | −¥292m | 2023-10-01 → 2023-12-31 | Standalone | Ordinary income |
| Ordinary income | −¥1.4bn | 2022-10-01 → 2023-09-30 | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | −¥324m | 2022-10-01 → 2022-12-31 | Standalone | Ordinary income |
| Profit before tax | −¥292m | 2023-10-01 → 2023-12-31 | Standalone | Income before income taxes |
| Profit before tax | −¥324m | 2022-10-01 → 2022-12-31 | Standalone | Income before income taxes |
| Net income | −¥293m | 2023-10-01 → 2023-12-31 | Standalone | Profit loss |
| Net income | −¥1.4bn | 2022-10-01 → 2023-09-30 | Standalone | Net income loss (5-year summary) |
| Net income | −¥326m | 2022-10-01 → 2022-12-31 | Standalone | Profit loss |
| Total assets | ¥6.3bn | at 2023-12-31 | Standalone | Assets |
| Total assets | ¥5.6bn | at 2023-09-30 | Standalone | Assets |
| Total assets | ¥5.5bn | at 2022-12-31 | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥549m | at 2023-12-31 | Standalone | Liabilities |
| Total liabilities | ¥590m | at 2023-09-30 | Standalone | Liabilities |
| Net assets / equity | ¥5.8bn | at 2023-12-31 | Standalone | Net assets |
| Net assets / equity | ¥5.0bn | at 2023-09-30 | Standalone | Net assets |
| Net assets / equity | ¥5.0bn | at 2022-12-31 | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥5.0bn | at 2023-12-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥4.4bn | at 2023-09-30 | Standalone | Cash and deposits |
| EPS (basic) | ¥-1.2 | 2023-10-01 → 2023-12-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-6.65 | 2022-10-01 → 2023-09-30 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-1.54 | 2022-10-01 → 2022-12-31 | Standalone | Basic earnings loss per share (5-year summary) |
| Equity ratio | 91.3% | at 2023-12-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 89.2% | at 2023-09-30 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 91.8% | at 2022-12-31 | Standalone | Equity to asset ratio (5-year summary) |
| Shares issued | 253,510,757 | at 2023-12-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 232,160,757 | at 2023-09-30 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 211,730,423 | at 2022-12-31 | Standalone | Total number of issued shares (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 20
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | segment profit | 2023-10-01 → 2023-12-31 | −¥147m |
| jpcrp040300-q1r_E05351-000Cellular And Tissue Based Product Businessreportable segment | revenue | 2023-10-01 → 2023-12-31 | ¥56,000 |
| jpcrp040300-q1r_E05351-000Cellular And Tissue Based Product Businessreportable segment | revenue external | 2023-10-01 → 2023-12-31 | ¥56,000 |
| jpcrp040300-q1r_E05351-000Cellular And Tissue Based Product Businessreportable segment | segment profit | 2023-10-01 → 2023-12-31 | −¥115m |
| jpcrp040300-q1r_E05351-000Contract Cell Manufacturing Businessreportable segment | revenue | 2023-10-01 → 2023-12-31 | ¥248m |
| jpcrp040300-q1r_E05351-000Contract Cell Manufacturing Businessreportable segment | revenue external | 2023-10-01 → 2023-12-31 | ¥248m |
| jpcrp040300-q1r_E05351-000Contract Cell Manufacturing Businessreportable segment | segment profit | 2023-10-01 → 2023-12-31 | −¥32m |
| —segment total | revenue | 2023-10-01 → 2023-12-31 | ¥248m |
| —segment total | revenue external | 2023-10-01 → 2023-12-31 | ¥248m |
| —segment total | segment profit | 2023-10-01 → 2023-12-31 | −¥147m |
| Reconciling Itemsreconciling | segment profit | 2022-10-01 → 2022-12-31 | −¥161m |
| jpcrp040300-q1r_E05351-000Cellular And Tissue Based Product Businessreportable segment | revenue | 2022-10-01 → 2022-12-31 | ¥158,000 |
| jpcrp040300-q1r_E05351-000Cellular And Tissue Based Product Businessreportable segment | revenue external | 2022-10-01 → 2022-12-31 | ¥158,000 |
| jpcrp040300-q1r_E05351-000Cellular And Tissue Based Product Businessreportable segment | segment profit | 2022-10-01 → 2022-12-31 | −¥107m |
| jpcrp040300-q1r_E05351-000Contract Cell Manufacturing Businessreportable segment | revenue | 2022-10-01 → 2022-12-31 | ¥185m |
| jpcrp040300-q1r_E05351-000Contract Cell Manufacturing Businessreportable segment | revenue external | 2022-10-01 → 2022-12-31 | ¥185m |
| jpcrp040300-q1r_E05351-000Contract Cell Manufacturing Businessreportable segment | segment profit | 2022-10-01 → 2022-12-31 | −¥57m |
| —segment total | revenue | 2022-10-01 → 2022-12-31 | ¥185m |
| —segment total | revenue external | 2022-10-01 → 2022-12-31 | ¥185m |
| —segment total | segment profit | 2022-10-01 → 2022-12-31 | −¥164m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 307
| Item | Context | Value | Unit |
|---|---|---|---|
| Operating income | Prior1YTDDuration_NonConsolidatedMember_ReportableSegmentsMember | -164435000 | JPY |
| Operating income | Prior1YTDDuration_NonConsolidatedMember_ReconcilingItemsMember | -161063000 | JPY |
| Operating income | Prior1YTDDuration_NonConsolidatedMember | -325498000 | JPY |
| Revenues from external customers | CurrentYTDDuration_NonConsolidatedMember_jpcrp040300-q1r_E05351-000ContractCellManufacturingBusinessReportableSegmentsMember | 248179000 | JPY |
| Revenues from external customers | CurrentYTDDuration_NonConsolidatedMember_jpcrp040300-q1r_E05351-000CellularAndTissueBasedProductBusinessReportableSegmentsMember | 56000 | JPY |
| Revenues from external customers | CurrentYTDDuration_NonConsolidatedMember_ReportableSegmentsMember | 248236000 | JPY |
| Revenues from external customers | CurrentYTDDuration_NonConsolidatedMember_ReconcilingItemsMember | － | JPY |
| Revenues from external customers | CurrentYTDDuration_NonConsolidatedMember | 248236000 | JPY |
| Transactions with other segments | CurrentYTDDuration_NonConsolidatedMember_jpcrp040300-q1r_E05351-000ContractCellManufacturingBusinessReportableSegmentsMember | － | JPY |
| Transactions with other segments | CurrentYTDDuration_NonConsolidatedMember_jpcrp040300-q1r_E05351-000CellularAndTissueBasedProductBusinessReportableSegmentsMember | － | JPY |
| Transactions with other segments | CurrentYTDDuration_NonConsolidatedMember_ReportableSegmentsMember | － | JPY |
| Transactions with other segments | CurrentYTDDuration_NonConsolidatedMember_ReconcilingItemsMember | － | JPY |
| Transactions with other segments | CurrentYTDDuration_NonConsolidatedMember | － | JPY |
| Net sales | CurrentYTDDuration_NonConsolidatedMember_jpcrp040300-q1r_E05351-000ContractCellManufacturingBusinessReportableSegmentsMember | 248179000 | JPY |
| Net sales | CurrentYTDDuration_NonConsolidatedMember_jpcrp040300-q1r_E05351-000CellularAndTissueBasedProductBusinessReportableSegmentsMember | 56000 | JPY |
| Net sales | CurrentYTDDuration_NonConsolidatedMember_ReportableSegmentsMember | 248236000 | JPY |
| Net sales | CurrentYTDDuration_NonConsolidatedMember_ReconcilingItemsMember | － | JPY |
| Net sales | CurrentYTDDuration_NonConsolidatedMember | 248236000 | JPY |
| Operating income | CurrentYTDDuration_NonConsolidatedMember_jpcrp040300-q1r_E05351-000ContractCellManufacturingBusinessReportableSegmentsMember | -31623000 | JPY |
| Operating income | CurrentYTDDuration_NonConsolidatedMember_jpcrp040300-q1r_E05351-000CellularAndTissueBasedProductBusinessReportableSegmentsMember | -115130000 | JPY |
| Operating income | CurrentYTDDuration_NonConsolidatedMember_ReportableSegmentsMember | -146753000 | JPY |
| Operating income | CurrentYTDDuration_NonConsolidatedMember_ReconcilingItemsMember | -147155000 | JPY |
| Operating income | CurrentYTDDuration_NonConsolidatedMember | -293909000 | JPY |
| Document title cover page | FilingDateInstant | Original text (Japanese)四半期報告書 | |
| Clause of stipulation cover page | FilingDateInstant | Original text (Japanese)金融商品取引法第24条の４の７第１項 | |
| Place of filing cover page | FilingDateInstant | Original text (Japanese)関東財務局長 | |
| Filing date cover page | FilingDateInstant | 2024-02-13 | |
| Quarterly accounting period cover page | FilingDateInstant | Original text (Japanese)第29期第１四半期（自 2023年10月１日 至 2023年12月31日） | |
| Company name cover page | FilingDateInstant | Original text (Japanese)株式会社メディネット | |
| Company name in english cover page | FilingDateInstant | MEDINET Co., Ltd. | |
| Title and name of representative cover page | FilingDateInstant | Original text (Japanese)代表取締役社長 久布白 兼直 | |
| Address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)東京都品川区勝島一丁目５番21号（同所は登記上の本店所在地であり、実際の業務は「最寄りの連絡場所」で行っております。） | |
| Telephone number address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)該当事項はありません。 | |
| Name of contact person address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)該当事項はありません。 | |
| Nearest place of contact cover page | FilingDateInstant | Original text (Japanese)東京都大田区平和島六丁目１番１号 | |
| Telephone number nearest place of contact cover page | FilingDateInstant | Original text (Japanese)（０３）６６３１－１２０１（代表） | |
| Name of contact person nearest place of contact cover page | FilingDateInstant | Original text (Japanese)取締役経営管理部長 落合 雅三 | |
| Place for public inspection cover page (text) | FilingDateInstant | Text · Plus | |
| Edinet code | FilingDateInstant | E05351 | |
| Fund code | FilingDateInstant | － | |
| Security code | FilingDateInstant | 23700 | |
| Filer name in japanese | FilingDateInstant | Original text (Japanese)株式会社メディネット | |
| Filer name in english | FilingDateInstant | MEDINET Co., Ltd. | |
| Fund name in japanese | FilingDateInstant | － | |
| Fund name in english | FilingDateInstant | － | |
| Cabinet office ordinance | FilingDateInstant | Original text (Japanese)企業内容等の開示に関する内閣府令 | |
| Document type | FilingDateInstant | Original text (Japanese)第四号の三様式 | |
| Accounting standards | FilingDateInstant | Japan GAAP | |
| Whether consolidated financial statements are prepared | FilingDateInstant | false | |
| Industry code when consolidated financial statements are prepared in accordance with industry specific regulations | FilingDateInstant | － |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 10 of 10 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |